Since we observed that Fisetin administration is able to normalize oxidative stress parameters (Figures 2–4) in the HCC liver, it was speculated that such a biochemical change may diminish upregulated profile of TNFα and IL1α as well. The gene discussed is IL1A; the disease is hepatocellular carcinoma.